Experts at the 2025 Clinical Trial Supply Europe will explore supply chain challenges and the impact of AI on trials.

Sanofi has completed the spin-out of its pharma ... producers in countries like India and China, particularly as supply chains became disrupted by COVID-19, and those concerns have only been ...

He added that there has been “no interruption” to manufacturing or the supply of drugs from the Framingham site tied to the FDA’s production rebuke. Sanofi scores with its subcutaneous ...

Sanofi will invest more than €1 billion ... EU on manufacturing capacity in other parts of the world and boost supply chain security and resiliency. The move ties in with the EU’s position ...